Volume 25 - Issue 12 - December 2017

hair loss
The FDA has granted Fast Track designation to a novel therapy for the treatment of moderate-to-severe alopecia areata.
Jennifer Conner, MPAS, PA-C, and Jane Mast, MPAS, PA-C
Adnan A. Khan, MD; Adil Usman, MD, FAAD; and Amor Khachemoune, MD, FAAD, FACMS
Anne H. Boyd, MD, and Sara A. Hylwa, MD
Kathryn Anderson, MD; Leonora Bomar, MD; and Michael Farhangian, MD
Lisa B. Samalonis, Managing Editor
Jo-David Fine, MD, MPH, FRCP, and Ron J. Feldman, MD, PhD
Section Editor, Benjamin Barankin, MD, FRCPC

Homepage Highlight

Lisa B. Samalonis, Managing Editor